One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news / January 2017

Archive

✕

19 stycznia 2017

4156

People with mental disease are at higher risk of being HIV positive

People with mental disease are at higher risk of being HIV positive

According to the study published in the journal Psychiatric Services on Jan. 17, 2017, people with severe mental illness such as bipolar disorder, schizophrenia and major depression with psychosis might be up to 15 times likely to be HIV positive compared to general population.

19 stycznia 2017

3753

The Affordable Care Act repeal jeopardizes the efforts to end AIDS

The Affordable Care Act repeal jeopardizes the efforts to end AIDS

California along with other states made a significant progress in a fight against HIV in recent years. New diagnoses of HIV infection in the United States have decreased or stabilized among many populations.

18 stycznia 2017

4146

Scientists: ART might increase the risk of acquiring syphilis infection

Scientists: ART might increase the risk of acquiring syphilis infection

Syphilis is spreading at a high rate among homosexual and bisexual men infected with HIV-1. Scientists explain this as being due to the fact that antiretroviral therapy (ART) creates susceptibility for acquiring Treponema pallidum, the bacteria which causes the development ...

18 stycznia 2017

4066

Statins and vitamin D deficiency may cause muscle damage in people with HIV

Statins and vitamin D deficiency may cause muscle damage in people with HIV

Statins are medications which are prescribed to reduce the risk of cardiovascular disease by reducing cholesterol levels. Specifically, LDL cholesterol is responsible for the development of cardiovascular disease.

17 stycznia 2017

3621

HIV neutralizing antibodies show promise

HIV neutralizing antibodies show promise

A collaborative team of German and American scientists published results of successful test of the HIV neutralizing antibody 10-1074. This new generation of highly potent antibodies is able to neutralize a number of HIV strains.

17 stycznia 2017

3970

Zimbabwe: Major step in a fight against HIV

Zimbabwe: Major step in a fight against HIV

After adopting World Health Organisation (WHO) guidelines on HIV treatment and prevention, Zimbabwe will soon start pre-exposure prophylaxis (PrEP) programs in selected districts in the country. The programs will include people who do not have HIV but at risk of acquiring ...

16 stycznia 2017

3907

Tribunal in Kenya rules in favor of victims of HIV stigma

Tribunal in Kenya rules in favor of victims of HIV stigma

The HIV and Aids Tribunal (HAT) in Kenya, responsible for hearing HIV discrimination cases and illegal disclosure cases, has awarded millions of shillings to HIV-positive individuals. Since 2012 there have been 348 cases claiming unlawful treatment of people living with ...

16 stycznia 2017

4031

Study: High match between self-reported viral load and clinic-recorded viral load in PLWH in Great Britain

Study: High match between self-reported viral load and clinic-recorded viral load in PLWH in Great Britain

According to a study published in HIV Medicine there is a high accuracy of a self-report of undetectable VL among people receiving ART in the UK. The study took place in the United Kingdom and involved 2678 people receiving antiretroviral treatment. Over two-thirds (68%) ...

16 stycznia 2017

4167

Charlie Sheen opens up about his life with HIV

Charlie Sheen opens up about his life with HIV

In his emotional new interview more than a year after he went public about his HIV status, famous actor spoke about his life. Charlie revealed that he was HIV positive in November 2015, four years after he was diagnosed.

13 stycznia 2017

4625

EU approves hepatitis B therapy Vemlidy

EU approves hepatitis B therapy Vemlidy

Gilead Sciences, Inc. on January 11 announced that the European Commission has granted marketing authorization for Vemlidy (tenofovir alafenamide, TAF) 25 mg, a once-daily tablet for the treatment of chronic hepatitis B virus (HBV) infection in adults and adolescents (aged ...

1 2 3 4 5